All Stories

  1. Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables
  2. Fetal and early neonatal interleukin-6 response
  3. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease
  4. Long Chain Omega-3 Fatty Acids in Pediatric Metabolic Syndrome
  5. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents
  6. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease
  7. Helicobacter pylori infection and extragastric disorders in children: A critical update
  8. Probiotics for the treatment of Helicobacter pylori infection in children
  9. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease
  10. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease
  11. Procalcitonin in Pediatrics
  12. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease
  13. Hepatic Steatosis and Thyroid Function Tests in Overweight and Obese Children
  14. Thyroid function in childhood obesity and metabolic comorbidity
  15. Gestational- and age-specific CRP reference intervals in the newborn
  16. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents
  17. Giant Cell Hepatitis with Autoimmune Hemolytic Anemia in Early Childhood: Long-Term Outcome in 16 Children
  18. Management of metabolic syndrome in children and adolescents
  19. C reactive protein and procalcitonin: Reference intervals for preterm and term newborns during the early neonatal period
  20. T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease
  21. Helicobacter pylori Therapy in Children: A Focus on Proton Pump Inhibitors
  22. Mutational analysis of ABCC2 gene in two siblings with neonatal-onset Dubin Johnson syndrome
  23. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease
  24. Consequences of Helicobacter pylori infection in children
  25. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge
  26. Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome
  27. Circulating Leptin, Ghrelin, Glucose, Insulin, C-Peptide, GH, IGF-1, Cortisol, and Interleukin-6 Concentrations, and the Systemic Stress Response to Uncomplicated Surgical Injury
  28. Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents
  29. Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: A preliminary report
  30. Breath tests in pediatrics
  31. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children
  32. Nonalcoholic Fatty Liver Disease and Carotid Atherosclerosis in Children
  33. Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?
  34. Long-term effects of Helicobacter pylori eradication on circulating ghrelin and leptin concentrations and body composition in prepubertal children
  35. How do we care for children with fatty liver disease?
  36. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease
  37. Increased T-helper interferon- -secreting cells in obese children
  38. Neonatal Candida albicans Septic Thrombosis of the Portal Vein followed by Cavernous Transformation of the Vessel
  39. Tacrolimus and food allergy
  40. Spondyloarthropathy and chronic intestinal inflammation in children: a new entity in the spectrum of pediatric inflammatory bowel disease?
  41. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia
  42. C-Reactive Protein, Interleukin-6, and Procalcitonin in the Immediate Postnatal Period: Influence of Illness Severity, Risk Status, Antenatal and Perinatal Complications, and Infection
  43. Serum Procalcitonin Concentrations in Delivering Mothers
  44. Umbilical Cord Interleukin-6 Levels Are Elevated in Neonates with Hypoxic-Ischemic Encephalopathy
  45. Serum procalcitonin concentrations in delivering mothers
  46. Azithromycin in children: A critical review of the evidence
  47. Patronage lies at the heart of Italy's academic problems
  48. Chemokine Concentrations in Nasal Washings of Infants with Rhinovirus Illnesses
  49. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit
  50. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit
  51. Reply
  52. Procalcitonin in pediatrics: Overview and challenge
  53. Reliability of Procalcitonin Concentrations for the Diagnosis of Sepsis in Critically III Neonates
  54. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population
  55. EFFICACY OF THREE-DAY AZITHROMYCIN VS. TEN-DAY PENICILLIN V IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS
  56. Interleukin 6 in neonates with early and late onset infection
  57. Prospective study of Yersinia enterocolitica infection in thalassemic patients
  58. Elevated White Blood Cell Counts Associated with Ureaplasma urealyticum Colonization in Preterm Neonates
  59. Yersinia enterocolitica causing suppurative arthritis of the shoulder.
  60. Recurrent Attacks of Scarlet Fever
  61. ACUTE GUTTATE PSORIASIS AFTER STREPTOCOCCAL SCARLET FEVER
  62. Yersinia pseudotubetculosisin Italy. Attempted Recovery from 37,666 Samples
  63. Body Surface Cultures in the Neonatal Intensive Care Unit
  64. 86 GENERALIZED YERSINIA ENIEROCOLITICA(YE) INFBCTION IN THALASSEMIC CHILDREN
  65. Clostridium difficile Isolation in Leukemic Children on Maintenance Cancer Chemotherapy